NCT03621982 2024-06-13Study of ADCT-301 in Patients With Selected Advanced Solid TumorsADC Therapeutics S.A.Phase 1 Terminated78 enrolled 39 charts
NCT02834052 2024-06-07Pembrolizumab + Poly-ICLC in MRP Colon CancerAugusta UniversityPhase 1/2 Completed42 enrolled 13 charts
NCT03332498 2022-06-03Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal CancersH. Lee Moffitt Cancer Center and Research InstitutePhase 1/2 Completed40 enrolled 12 charts